The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Non-Fluent Variant Primary Progressive Aphasia (nfvPPA)

Slowly progressive language disorder with effortful speech and agrammatism from frontotemporal pathology.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Nöroloji department. Book Appointment →

What is Non-Fluent Variant Primary Progressive Aphasia (nfvPPA)?

Non-fluent/agrammatic variant primary progressive aphasia (nfvPPA) is one of three primary progressive aphasia subtypes alongside semantic and logopenic variants. Patients present with effortful, halting, distorted speech, agrammatism in production and comprehension of complex syntax, apraxia of speech, and relatively preserved single-word comprehension and object knowledge. Cognitive function in non-language domains is initially preserved but gradually declines.

Underlying pathology is most often tauopathy (corticobasal degeneration, progressive supranuclear palsy, Pick's disease) in 70 percent, with TDP-43 type A pathology in a minority. The clinical phenotype frequently overlaps and progresses to corticobasal syndrome with limb apraxia and parkinsonism, or to progressive supranuclear palsy with vertical gaze palsy and falls. Brain MRI shows asymmetric left posterior frontoinsular and dorsolateral frontal atrophy.

Diagnosis is clinical (Gorno-Tempini criteria 2011) supported by speech-language pathologist evaluation, brain MRI showing left frontal atrophy, FDG-PET showing left frontoinsular hypometabolism, and amyloid/tau PET to identify underlying proteinopathy. Management is symptomatic: speech therapy with augmentative and alternative communication, dysphagia evaluation, caregiver education, fall prevention, and palliative planning. Disease-modifying therapies are limited; future tau-targeted therapies are in trials.

Symptoms

Effortful halting speech with errors
Agrammatism in sentence production
Apraxia of speech with sound distortion
Preserved single-word comprehension early
Difficulty understanding complex sentences
Speech sound substitution and groping
Right limb clumsiness or rigidity (overlap)

Risk Factors

Age 55-75 years at onset
Family history of FTD (rare familial)
MAPT, GRN, C9orf72 mutations
Underlying CBD or PSP tauopathy
Female sex (slight predominance)
Prior stuttering or language vulnerability
Frontotemporal lobar degeneration spectrum

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Progressive halting effortful speech
  • Word-finding plus apraxia of speech
  • Right limb clumsiness with speech changes
  • Difficulty with complex sentence comprehension
  • Family history of FTD with new aphasia

Treatment Methods

01
Detailed speech-language pathology evaluation
02
Brain MRI for left frontal atrophy pattern
03
FDG-PET and amyloid/tau PET
04
Speech therapy with AAC tools
05
Dysphagia evaluation and management
06
Caregiver and family education
07
Multidisciplinary palliative care planning

Which Department to Visit?

You can visit our Nöroloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Nöroloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.